The benefits of continuous processing are numerous. Switching from batch manufacturing can reduce costs and increase efficiency throughout operations. Continuous processing can also address several issues that have become more prominent during the coronavirus pandemic. Yet, pharma has yet to fully jump on the continuous bandwagon. “Continuous processing is one approach to cut processing costs common in many industries, but — due to regulatory concerns — pharma has been a relatively slow adopter,” explains Florian Walter, product manager at Watson-Marlow Fluid Technology Group. In addition to regulatory hurdles, manufacturers looking to transition to continuous face a number of other operational challenges. But pharma vendors are innovating solutions that can help manufacturers leverage the benefits of going continuous. Click Here For Complete Article Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
||||||||||||